Dmitry Lyakhov
About Dmitry Lyakhov
Dmitry Lyakhov is a Principal Scientist and Associate Director at Bristol Myers Squibb in Seattle, Washington, with over 20 years of experience in molecular diagnostics product development.
Title
Dmitry Lyakhov holds the title of Principal Scientist and Associate Director at Bristol Myers Squibb.
Current Position at Bristol Myers Squibb
Dmitry Lyakhov currently works as a Principal Scientist and Associate Director at Bristol Myers Squibb in Seattle, Washington. In this role, he leads analytical support for CAR T therapy programs, including BREYANZI and ABECMA, and serves as the technical lead for viral vector analytical development for CAR T therapy.
Previous Experience at NanoString Technologies
From 2016 to 2020, Dmitry Lyakhov worked as a Senior Scientist at NanoString Technologies, Inc. in the Greater Seattle Area. During his tenure, he contributed to various projects involving molecular diagnostics and biotechnology applications.
Career at Ionian Technologies
Before joining NanoString Technologies, Dmitry Lyakhov worked at Ionian Technologies (Alere Inc., now Abbott) as a Senior Scientist from 2013 to 2016 in the Greater San Diego Area. His work focused on molecular diagnostics and assay development.
Education and Expertise
Dmitry Lyakhov earned his PhD in Molecular Biology from the Russian Academy of Sciences and an MS in Biophysics from Lomonosov Moscow State University (MSU). With over 20 years of industrial experience, he is an expert in molecular diagnostics, genetic assay development, biochemistry, enzymology, protein engineering, and bioinformatics.
Early Career and Postdoctoral Research
Dmitry Lyakhov began his research career at the Institute for Molecular Biology, Russian Academy of Sciences, where he worked as a Research Scientist from 1985 to 1993. He then conducted postdoctoral research at the State University of New York, Health Science Center at Brooklyn (1993-1997) and the University of Pennsylvania (1997-1999).